Last reviewed · How we verify
MEPROBAMATE
At a glance
| Generic name | MEPROBAMATE |
|---|---|
| Modality | Small molecule |
| Phase | FDA-approved |
| First approval | 1955 |
Approved indications
Common side effects
- Drowsiness
- Ataxia
- Dizziness
- Slurred speech
- Headache
- Vertigo
- Weakness
- Paresthesias
- Impairment of visual accommodation
- Euphoria
- Overstimulation
- Paradoxical excitement
Serious adverse events
- Hypotensive crisis
- Syncope
- Arrhythmia
- Stevens-Johnson syndrome
- Anaphylaxis
- Agranulocytosis
- Aplastic anemia
- Exfoliative dermatitis
- Angioneurotic edema
- Bronchospasm
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |